The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jankovic, D.
Right arrow Articles by Sher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jankovic, D.
Right arrow Articles by Sher, A.
The Journal of Immunology, 1999, 163: 337-342.
Copyright © 1999 by The American Association of Immunologists

Schistosome-Infected IL-4 Receptor Knockout (KO) Mice, in Contrast to IL-4 KO Mice, Fail to Develop Granulomatous Pathology While Maintaining the Same Lymphokine Expression Profile1

Dragana Jankovic2,3,*, Marika C. Kullberg2,*, Nancy Noben-Trauth{dagger}, Patricia Caspar*, Jerrold M. Ward{ddagger}, Allen W. Cheever*, William E. Paul{dagger} and Alan Sher*

* Immunobiology Section, Laboratory of Parasitic Diseases, and {dagger} Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; {ddagger} Animal Science Branch, National Cancer Institute, National Institutes of Health, Frederick, MD 21702; and § Biomedical Research Institute, Rockville, MD 20852

Th2 lymphocytes have been postulated to play a major role in the immunopathology induced by Schistosoma mansoni infection. Nevertheless, infected IL-4 knockout (KO) and wild-type (wt) mice develop egg granulomas comparable in size. To further investigate the function of the Th2 response in egg pathology we studied IL-4R{alpha}-deficient mice, which are nonresponsive to both IL-4 and IL-13. In striking contrast to IL-4 KO animals, infected IL-4R{alpha} KO mice developed only minimal hepatic granulomas and fibrosis despite the presence of CD3+ T cells in the residual egg lesions. Moreover, liver lymphokine mRNA levels in these animals and IL-4 KO mice were equivalent. In addition, infected IL-4R{alpha}-deficient, IL-4-deficient, and wt animals developed similar egg Ag-specific IgG Ab titers, arguing that CD4-dependent Th activity is intact in KO mice. As expected, IFN-{gamma} secretion was strongly up-regulated in mesenteric lymph node cultures from both groups of deficient animals, a change reflected in increased serum IgG2a and IgG2b Ab levels. Surprisingly, Th2 cytokine production in infected IL-4R{alpha} KO mice was not abolished but was only reduced and resembled that previously documented in IL-4 KO animals. This residual Th2 response is likely to explain the ability of IL-4 KO mice to generate egg granulomas, which cannot be formed in IL-4R{alpha}-deficient animals because of their lack of responsiveness to the same cytokine ligands. Taken together, these findings argue that tissue pathology in schistosomiasis requires, in addition to egg-specific CD4+ lymphocytes, a previously unrecognized IL-4R{alpha}+ non-T cell effector population.




This article has been cited by other articles:


Home page
J. Immunol.Home page
T. R. Ramalingam, J. T. Pesce, M. M. Mentink-Kane, S. Madala, A. W. Cheever, M. R. Comeau, S. F. Ziegler, and T. A. Wynn
Regulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin
J. Immunol., May 15, 2009; 182(10): 6452 - 6459.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Zhu, D. Jankovic, A. Grinberg, L. Guo, and W. E. Paul
Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion
PNAS, November 28, 2006; 103(48): 18214 - 18219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Leeto, D. R. Herbert, R. Marillier, A. Schwegmann, L. Fick, and F. Brombacher
TH1-Dominant Granulomatous Pathology Does Not Inhibit Fibrosis or Cause Lethality during Murine Schistosomiasis
Am. J. Pathol., November 1, 2006; 169(5): 1701 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Balic, Y. M. Harcus, M. D. Taylor, F. Brombacher, and R. M. Maizels
IL-4R signaling is required to induce IL-10 for the establishment of Th2 dominance
Int. Immunol., October 1, 2006; 18(10): 1421 - 1431.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. L. Cannons, L. J. Yu, D. Jankovic, S. Crotty, R. Horai, M. Kirby, S. Anderson, A. W. Cheever, A. Sher, and P. L. Schwartzberg
SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation
J. Exp. Med., June 12, 2006; 203(6): 1551 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. M. Reiman, R. W. Thompson, C. G. Feng, D. Hari, R. Knight, A. W. Cheever, H. F. Rosenberg, and T. A. Wynn
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Infect. Immun., March 1, 2006; 74(3): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Arora, Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Role of IFN-{gamma} in Regulating T2 Immunity and the Development of Alternatively Activated Macrophages during Allergic Bronchopulmonary Mycosis
J. Immunol., May 15, 2005; 174(10): 6346 - 6356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kaviratne, M. Hesse, M. Leusink, A. W. Cheever, S. J. Davies, J. H. McKerrow, L. M. Wakefield, J. J. Letterio, and T. A. Wynn
IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-{beta} Independent
J. Immunol., September 15, 2004; 173(6): 4020 - 4029.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Q. Liu, C. Arseculeratne, Z. Liu, J. Whitmire, M. J. Grusby, F. D. Finkelman, T. N. Darling, A. W. Cheever, J. Swearengen, J. F. Urban, et al.
Simultaneous Deficiency in CD28 and STAT6 Results in Chronic Ectoparasite-Induced Inflammatory Skin Disease
Infect. Immun., July 1, 2004; 72(7): 3706 - 3715.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Woolard, L. M. Hodge, H. P. Jones, T. R. Schoeb, and J. W. Simecka
The Upper and Lower Respiratory Tracts Differ in Their Requirement of IFN-{gamma} and IL-4 in Controlling Respiratory Mycoplasma Infection and Disease
J. Immunol., June 1, 2004; 172(11): 6875 - 6883.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Cote-Sierra, G. Foucras, L. Guo, L. Chiodetti, H. A. Young, J. Hu-Li, J. Zhu, and W. E. Paul
Interleukin 2 plays a central role in Th2 differentiation
PNAS, March 16, 2004; 101(11): 3880 - 3885.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Mentink-Kane, A. W. Cheever, R. W. Thompson, D. M. Hari, N. B. Kabatereine, B. J. Vennervald, J. H. Ouma, J. K. Mwatha, F. M. Jones, D. D. Donaldson, et al.
IL-13 receptor {alpha} 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis
PNAS, January 13, 2004; 101(2): 586 - 590.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. B. Stavitsky
Regulation of Granulomatous Inflammation in Experimental Models of Schistosomiasis
Infect. Immun., January 1, 2004; 72(1): 1 - 12.
[Full Text] [PDF]


Home page
JEMHome page
M. G. Chiaramonte, M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E.P. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, et al.
Regulation and Function of the Interleukin 13 Receptor {alpha} 2 During a T Helper Cell Type 2-dominant Immune Response
J. Exp. Med., March 17, 2003; 197(6): 687 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Johnson, R. A. Parker, J. E. Johnson, and B. S. Graham
IL-13 Is Sufficient for Respiratory Syncytial Virus G Glycoprotein-Induced Eosinophilia After Respiratory Syncytial Virus Challenge
J. Immunol., February 15, 2003; 170(4): 2037 - 2045.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Hogan, M. Wang, M. Suresh, D. O. Co, J. V. Weinstock, and M. Sandor
CD4+ TCR Repertoire Heterogeneity in Schistosoma mansoni-Induced Granulomas
J. Immunol., December 1, 2002; 169(11): 6386 - 6393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Jakubzick, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
Interleukin-13 Fusion Cytotoxin Arrests Schistosoma mansoni Egg-Induced Pulmonary Granuloma Formation in Mice
Am. J. Pathol., October 1, 2002; 161(4): 1283 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Yagi, H. Nagai, Y. Iigo, T. Akimoto, T. Arai, and M. Kubo
Development of Atopic Dermatitis-Like Skin Lesions in STAT6-Deficient NC/Nga Mice
J. Immunol., February 15, 2002; 168(4): 2020 - 2027.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. A. Patton, A. C. La Flamme, J. A. Pedras-Vasoncelos, and E. J. Pearce
Central Role for Interleukin-4 in Regulating Nitric Oxide-Mediated Inhibition of T-Cell Proliferation and Gamma Interferon Production in Schistosomiasis
Infect. Immun., January 1, 2002; 70(1): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. C. La Flamme, E. A. Patton, and E. J. Pearce
Role of Gamma Interferon in the Pathogenesis of Severe Schistosomiasis in Interleukin-4-Deficient Mice
Infect. Immun., December 1, 2001; 69(12): 7445 - 7452.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Blease, C. Jakubzick, J. Westwick, N. Lukacs, S. L. Kunkel, and C. M. Hogaboam
Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma
J. Immunol., April 15, 2001; 166(8): 5219 - 5224.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Wangoo, T. Sparer, I. N. Brown, V. A. Snewin, R. Janssen, J. Thole, H. T. Cook, R. J. Shaw, and D. B. Young
Contribution of Th1 and Th2 Cells to Protection and Pathology in Experimental Models of Granulomatous Lung Disease
J. Immunol., March 1, 2001; 166(5): 3432 - 3439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. La Flamme, E. A. Patton, B. Bauman, and E. J. Pearce
IL-4 Plays a Crucial Role in Regulating Oxidative Damage in the Liver During Schistosomiasis
J. Immunol., February 1, 2001; 166(3): 1903 - 1911.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. P. Mountford, K. G. Hogg, P. S. Coulson, and F. Brombacher
Signaling via Interleukin-4 Receptor {alpha} Chain Is Required for Successful Vaccination against Schistosomiasis in BALB/c Mice
Infect. Immun., January 1, 2001; 69(1): 228 - 236.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. A. Patton, L. R. Brunet, A. C. La Flamme, J. Pedras-Vasconcelos, M. Kopf, and E. J. Pearce
Severe Schistosomiasis in the Absence of Interleukin-4 (IL-4) Is IL-12 Independent
Infect. Immun., January 1, 2001; 69(1): 589 - 592.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. R. Potter, N. Noben-Trauth, J. H. Weis, C. Teuscher, and J. J. Weis
Interleukin-4 (IL-4) and IL-13 Signaling Pathways Do Not Regulate Borrelia burgdorferi-Induced Arthritis in Mice: IgG1 Is Not Required for Host Control of Tissue Spirochetes
Infect. Immun., October 1, 2000; 68(10): 5603 - 5609.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. F. Hoffmann, A. W. Cheever, and T. A. Wynn
IL-10 and the Dangers of Immune Polarization: Excessive Type 1 and Type 2 Cytokine Responses Induce Distinct Forms of Lethal Immunopathology in Murine Schistosomiasis
J. Immunol., June 15, 2000; 164(12): 6406 - 6416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Jankovic, M. C. Kullberg, N. Noben-Trauth, P. Caspar, W. E. Paul, and A. Sher
Single Cell Analysis Reveals That IL-4 Receptor/Stat6 Signaling Is Not Required for the In Vivo or In Vitro Development of CD4+ Lymphocytes with a Th2 Cytokine Profile
J. Immunol., March 15, 2000; 164(6): 3047 - 3055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. G. Fallon, E. J. Richardson, G. J. McKenzie, and A. N. J. McKenzie
Schistosome Infection of Transgenic Mice Defines Distinct and Contrasting Pathogenic Roles for IL-4 and IL-13: IL-13 Is a Profibrotic Agent
J. Immunol., March 1, 2000; 164(5): 2585 - 2591.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.